The purpose of this pilot study was to assess the feasibility of Cadence contrast pulse sequencing ultrasound to predict clinical and angiogenic tumor response in dogs undergoing chemotherapy. Contrast ultrasound facilitated visualization of bladder tumors but failed to identify a straightforward relationship between ultrasound measures and clinical outcome.
|Original language||English (US)|
|Number of pages||3|
|Journal||Canadian Veterinary Journal|
|State||Published - Jan 1 2017|
ASJC Scopus subject areas